# Cynthia Yee

> Cynthia Yee is a Series B investor at Vensana Capital backing Health Care. See 4 investments, check sizes, portfolio and contact details. Updated Oct 2026.

- Type: Angel Investor
- Fund: [Vensana Capital](https://shizune.co/investors/profile/vensana-capital)
- Location: San Francisco, United States
- Total investments: 4
- Last investment: Mar 2025
- Lead investor: 75%
- Last updated: Oct 2026

Cynthia Yee is a Partner at Vensana Capital. Prior to joining Vensana, Cynthia served as a Principal at Windham Venture Partners where she led the firm's investments in Cartiva Medical, ClarVista Medical, Personal Genome Diagnostics, and Neuspera Medical and helped open the firm's San Francisco office. Previously, Cynthia served asDirector of Business Development & Strategic Marketing at Epix Therapeutics (fka Advanced Cardiac Therapeutics) and medtech incubator D3 Development Corp, which spun-out three companies, including Spirox. Cynthia was also an investor on the Healthcare team at New Enterprise Associates (NEA) and focused on investments in medical device, biopharmaceutical and healthcare services companies. At NEA, Cynthia helped allocate over $250M in capital to healthcare companies in the peripheral and cardiovascular, spine, diabetes, urology and women’s health industries. Cynthia began her career in equity research, covering medical devices at Piper Jaffray and biopharma at Pacific Growth Equities.

## Contacts

5 contacts available for Cynthia Yee: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/cynthia-yee?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 3 | 75% |
| Medical | 2 | 50% |
| Medical Device | 2 | 50% |
| Health Diagnostics | 2 | 50% |
| Wellness | 1 | 25% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 3 | 75% |
| Series A | 1 | 25% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Evident Vascular | Evident Vascular offers an advanced IVUS platform that leverages Artificial Intelligence to deliver superior Vascular. |  | Series B | Mar 25, 2025 | https://evidentvascular.com/ |
| Evident Vascular | Evident Vascular offers an advanced IVUS platform that leverages Artificial Intelligence to deliver superior Vascular. | $35M | Series A | Oct 17, 2023 | https://evidentvascular.com/ |
| Spyglass Ophthalmics | Spyglass Ophthalmics develops ophthalmic devices intended to improve vision and eye care of patients. Spyglass' devices address unmet needs in cataract, lens replacement, surgery, and other chronic ophthalmic diseases, enabling patients to get quality eye treatment at an affordable cost. | $27.5M | Series B | Jan 07, 2021 | https://spyglassophthalmics.com/ |
| ClarVista Medical | ClarVista Medical is a developer of innovative products to treat challenging ophthalmic conditions. In 2012 and in conjunction with series A financing, ClarVista was spun out from Prospex Medical, a medical device incubator, to pursue the development of the HARMONI™ IOL. Between 2012 and 2014, the company developed the first generation HARMONI™system, conducted thorough first-in-human clinical study and developed a broad portfolio of intellectual property. In 2015 the company closed on a series B financing of $14M which will be used to develop the second generation HAROMONI™ system, conduct a larger feasibility clinical trial and obtain key regulatory approvals including CE mark and US IDE. | $14.5M | Series B | May 20, 2015 | http://clarvistamedical.com |

4 of 4 investments shown.

## Co-investors
- [New Enterprise Associates](https://shizune.co/investors/profile/new-enterprise-associates) — VC Fund, 4 deals together
- [Cycad Group](https://shizune.co/investors/profile/cycad-group) — VC Fund, 1 deal together
- [Shangbay Capital](https://shizune.co/investors/profile/shangbay-capital) — VC Fund, 1 deal together

## About Vensana Capital

VC Fund · Minneapolis, United States

Vensana Capital is a venture capital investment firm that focuses on healthcare with breakthrough innovations in medical technology.

5 contacts available at Vensana Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Aaron Smith | Advisor | https://shizune.co/investors/profile/aaron-smith-4dea |
| Cynthia Yee | Partner | https://shizune.co/investors/profile/cynthia-yee |
| Greg Banker | Vice President | https://shizune.co/investors/profile/greg-banker-5544 |
| Justin Klein | Co-Founder & Managing Partner | https://shizune.co/investors/profile/justin-klein |
| Kirk Nielsen | Co-Founder & Managing Partner | https://shizune.co/investors/profile/kirk-nielsen-0ccf |

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Cynthia Yee invest in?

Cynthia Yee invests primarily in Health Care, Medical and Medical Device startups, most often at Series B and Series A stage. Most of the 4 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Cynthia Yee?

For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Cynthia Yee last invest?

The most recent investment recorded for Cynthia Yee closed in Mar 2025. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co